By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Titan Pharmaceuticals, Inc. 

400 Oyster Point Boulevard
Suite 505
South San Francisco  California  94080-1921  U.S.A.
Phone: 650-244-4990 Fax: 650-244-4956



Company News
Titan Pharma (TTNP) Added To Russell 3000 Index 6/28/2016 2:33:11 PM
Titan Pharma (TTNP) Announces First Patients Treated With Probuphine For Opioid Dependence 6/21/2016 11:22:58 AM
Titan Pharma (TTNP) Announces Rigorous Sensitivity Analyses Confirm Effectiveness Of Probuphine For Opioid Dependence 6/17/2016 11:35:55 AM
Titan Pharma (TTNP) Receives $15 Million Milestone Payment Following FDA Approval Of Probuphine 6/14/2016 1:30:31 PM
Titan Pharma (TTNP) Receives FDA Approval for the First Ever Implantable Device for Opioid Dependency 5/27/2016 6:25:02 AM
Titan Pharma (TTP) Reports First Quarter 2016 Financial Results 5/12/2016 11:38:53 AM
Titan Pharma (TTP) Schedules Conference Call To Review First Quarter 2016 Financial Results 5/5/2016 11:10:37 AM
Titan Pharma (TTP) Announces Presentation Of Probuphine Phase III Data At American Society Of Addiction Medicine Annual Conference 4/18/2016 11:58:42 AM
Titan Pharma (TTP) Reports Full Year And Fourth Quarter 2015 Financial Results 3/16/2016 10:03:03 AM
Titan Pharma (TTP) To Present At 28th Annual ROTH Conference 3/9/2016 11:36:18 AM